Actively Recruiting
Effects of Quercetin on Cardiometabolic Outcomes
Led by University of Central Lancashire · Updated on 2026-02-27
40
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
Sponsors
U
University of Central Lancashire
Lead Sponsor
D
DoNotAge.org
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Quercetin may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
CONDITIONS
Official Title
Effects of Quercetin on Cardiometabolic Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy
- Between 18 and 65 years old
- Non-smoker
- BMI less than 30
- Able to give informed consent
You will not qualify if you...
- Pregnancy
- Diabetes or any other metabolic or uncontrolled hypertensive conditions
- Food allergies to quercetin
- Habitual consumption of quercetin
- Not regularly taking medication or antioxidant supplements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Central Lancashire
Preston, Lancashire, United Kingdom, PR4 0PE
Actively Recruiting
Research Team
J
Jonathan Sinclair, PhD, DSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here